SCHEMBL17248181

SCHEMBL17248181

c1ccc(-c2nc(-c3ccccc3)nc(-n3c4ccccc4c4cc5c(cc43)c3ccccc3n5-c3cccc(-c4ccc5oc6ccccc6c5c4)c3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CHEK2 O96017 1/20 0.35
PLA2G2A P14555 4/20 0.35
PLA2G4A P47712 4/20 0.35
PLA2G10 O15496 1/20 0.35
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
NPC1 O15118 2/20 0.32
MAPT P10636 2/20 0.32
MEN1 O00255 1/20 0.32
RAB9A P51151 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.32
SIRT2 Q8IXJ6 1/20 0.32
SIRT1 Q96EB6 1/20 0.32
PTGER4 P35408 1/20 0.32
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16452331 0.99 KDM4E (0.36) KDM4EATML3MBTL1CHEK2PLA2G2A
SCHEMBL16452355 0.98 CHEK2 (0.36) KDM4EATML3MBTL1CHEK2PLA2G2A
SCHEMBL12691566 0.97 CHEK2 (0.35) KDM4EATML3MBTL1CHEK2PLA2G2A
SCHEMBL24914506 0.96 KDM4E (0.38) KDM4EATML3MBTL1CHEK2PLA2G2A
SCHEMBL27443747 0.95 L3MBTL1 (0.35) KDM4EATML3MBTL1CHEK2PLA2G2A
SCHEMBL25008996 0.95 PLA2G2A (0.36) KDM4EATML3MBTL1CHEK2PLA2G2A
SCHEMBL16452136 0.95 PLA2G2A (0.36) KDM4EATML3MBTL1CHEK2PLA2G2A
SCHEMBL27443749 0.95 L3MBTL1 (0.35) KDM4EATML3MBTL1CHEK2PLA2G2A
SCHEMBL23318012 0.95 PLA2G2A (0.37) KDM4EATML3MBTL1CHEK2PLA2G2A
SCHEMBL20634227 0.95 PLA2G2A (0.37) KDM4EATML3MBTL1CHEK2PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10361378-B2 Organic electroluminescent device NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2019-07-23 US disclosed
EP-2933851-B1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL & SUMIKIN CHEM CO (JP) 2017-05-10 EP disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10361378-B2 Organic electroluminescent device ELF3, DDT, LEF1 KDM4E 1228/4885ATM 3768/4885L3MBTL1 74/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.